Neuropathic pain models in the development of analgesic drugs

Scandinavian Journal of Pain - Tập 2 - Trang 172-177 - 2011
Per Hartvig Honoré1, Anna Basnet1, Laila Eljaja1, Pernille Kristensen1, Lene Munkholm Andersen1, Signe Neustrup1, Pia Møllgaard1, Ole J. Bjerrum1
1Department of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark

Tóm tắt

Abstract Introduction Animal disease models are predictive for signs seen in disease. They may rarely mimic all signs in a specific disease in humans with respect to etiology, cause or development. Several models have been developed for different pain states and the alteration of behavior has been interpreted as a response to external stimulus or expression of pain or discomfort. Considerable attention must be paid not to interpret other effects such as somnolence or motor impairment as a pain response and similarly not to misinterpret the response of analgesics. Neuropathic pain is caused by injury or disease of the somatosensory system. The clinical manifestations of neuropathic pain vary including both stimulus-evoked and non-stimulus evoked (spontaneous) symptoms. By pharmacological intervention, the threshold for allodynia and hyperalgesia in the various pain modalities can be modulated and measured in animals and humans. Animal models have been found most valuable in studies on neuropathic pain and its treatment. Aim of the study With these interpretation problems in mind, the present text aims to describe the most frequently used animal models of neuropathic pain induced by mechanical nerve injury. Methods The technical surgical performance of these models is described as well as pain behavior based on the authors own experience and from a literature survey. Results Nerve injury in the hind limb of rats and mice is frequently used in neuropathic pain models and the different types of lesion may afford difference in the spread and quality of the pain provoked. The most frequently used models are presented, with special focus on the spared nerve injury (SNI) and the spinal nerve ligation/transection (SNL/SNT) models, which are extensively used and validated in rats and mice. Measures of mechanical and thermal hypersensitivity with von Frey filaments and Hargreaves test, respectively, are described and shown in figures. Conclusions A number of animal models have been developed and described for neuropathic pain showing predictive value in parallel for both humans and animals. On the other hand, there are still large knowledge gaps in the pathophysiologic mechanisms for the development, maintenance and progression of the neuropathic pain syndrome Implications Better understanding of pathogenic mechanisms of neuropathic pain in animal models may support the search for new treatment paradigms in patients with complex neuropathic pain conditions

Tài liệu tham khảo

Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: re definition and a grading system for clinical and research purposes. Neurology 2008;70:1630–5.10.1212/01.wnl.0000282763.29778.59 Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003;102:1–8.10.1016/s0304-3959(03)00006-x12620591 Baron R. Neuropathic pain: a clinical perspective. Handb Exp Pharmacol 2009:3–30.19655103 Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001;429:23–37.1169802410.1016/S0014-2999(01)01303-6 Harty TP, Dib-Hajj SD, Tyrrell L, Blackman R, Hisama FM, Rose JB, Waxman SG. Na(V)1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons. J Neurosci 2006;26:12566–75.1713541810.1523/JNEUROSCI.3424-06.2006 Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, Ehnert C, Nejim J, Marian C, Scholz J, Wu T, Allchorne A, Diatchenko L, Binshtok AM, Goldman D, Adolph J, Sama S, Atlas SJ, Carlezon WA, Parsegian A, Lotsch J, Fillingim RB, Maixner W, Geisslinger G, Max MB, Woolf CJ. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006;12:1269–77.10.1038/nm149017057711 Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153–69.1703803010.1111/j.1468-1331.2006.01511.x Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237–51.1792077010.1016/j.pain.2007.08.033 Nozaki-Taguchi N, Chaplan SR, Higuera ES, Ajakwe RC, Yaksh TL. Vincristineinduced allodynia in the rat. Pain 2001;93:69–76.10.1016/S0304-3959(01)00294-9 Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87–107.10.1016/0304-3959(88)90209-62837713 Bridges D, Thompson SW, Rice AS. Mechanisms of neuropathic pain. Br J Anaesth 2001;87:12–26.10.1093/bja/87.1.1211460801 Wang LX, Wang ZJ. Animal and cellular models of chronic pain. Adv Drug Deliv Rev 2003;55:949–65.1293593910.1016/S0169-409X(03)00098-X Hogan Q. Animal pain models. Reg Anesth Pain Med 2002;27:385–401.10.1097/00115550-200207000-0000912132063 Kim KJ, Yoon YW, Chung JM. Comparison of three rodent neuropathic pain models. Exp Brain Res 1997;113:200–6.10.1007/BF024503189063706 Dowdall T, Robinson I, Meert TF. Comparison of five different rat models of peripheral nerve injury. Pharmacol Biochem Behav 2005;80:93–108.10.1016/j.pbb.2004.10.01615652385 Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000;87:149–58.10.1016/S0304-3959(00)00276-110924808 Rode F, Jensen DG, Blackburn-Munro G, Bjerrum OJ. Centrally-mediated antinociceptive actions of GABAA receptor agonists in the rat spared nerve injury model of neuropathic pain. Eur J Pharmacol 2005;516:131–8.10.1016/j.ejphar.2005.04.034 Bourquin AF, Suveges M, Pertin M, Gilliard N, Sardy S, Davison AC, Spahn DR, Decosterd I. Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. Pain 2006; 122:14.16542774 Erichsen HK, Blackburn-Munro G. Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain 2002;98:151–61.10.1016/S0304-3959(02)00039-812098627 Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355–63.10.1016/0304-3959(92)90041-91333581 Gustafsson H, Sandin J. Oral pregabalin reverses cold allodynia in two distinct models of peripheral neuropathic pain. Eur J Pharmacol 2009;605:103–8.10.1016/j.ejphar.2009.01.01419248226 Swett JE, Torigoe Y, Elie VR, Bourassa CM, Miller PG. Sensory neurons of the rat sciatic nerve. Exp Neurol 1991;114:82–103.191573810.1016/0014-4886(91)90087-S LaBuda CJ, Little PJ. Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat. J Neurosci Methods 2005;144:175–81.10.1016/j.jneumeth.2004.11.00815910975 Suzuki T, Ueta K, Tamagaki S, Mashimo T. Antiallodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation. Anesth Analg 2008;106:1309–15, table.10.1213/ane.0b013e318167889a18349211 Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC, Clohisy DR, Mantyh PW. Murine models of infiammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000;98:585–98.10.1016/S0306-4522(00)00110-X Minert A, Gabay E, Dominguez C, Wiesenfeld-Hallin Z, Devor M. Spontaneous pain following spinal nerve injury in mice. Exp Neurol 2007;206:220–30.1758590710.1016/j.expneurol.2007.04.011 Tawfik VL, Regan MR, Haenggeli C, Lacroix-Fralish ML, Nutile-McMenemy N, Perez N, Rothstein JD, DeLeo JA. Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience 2008;152:1086–92.1835862210.1016/j.neuroscience.2008.01.065 Sheen K, Chung JM. Signs of neuropathic pain depend on signals from injured nerve fibers in a rat model. Brain Res 1993;610:62–8.10.1016/0006-8993(93)91217-G Whiteside GT, Adedoyin A, Leventhal L. Predictive validity of animal pain models? A comparison of the pharmacokinetic–pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 2008;54:767–75.10.1016/j.neuropharm.2008.01.00118289614 Jarvis MF, Boyce-Rustay JM. Neuropathic pain: models and mechanisms. Curr Pharm Des 2009;15:1711–6.1944218510.2174/138161209788186272 Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990;43: 205–18.198234710.1016/0304-3959(90)91074-S Kontinen V, Meert T. Predictive validity of neuropathic pain models in pharmacological studies with behavioral outcome in the rat. In: Dostrovsky J, Carr D, Kolzenburg M, editors. Proceedings of the 10th world congress on pain. Seattle, WA: IASP Press; 2011. p. 489–98. Hole K, Tjolsen A. The tail-flick and formalin tests in rodents: changes in skin temperature as a confounding factor. Pain 1993;53:247–54.10.1016/0304-3959(93)90220-J8351154
Thông tin
Thông tin xuất bản

Scandinavian Journal of Pain

Tập 2

172-177

Thông tin tác giả